Y. D. Wang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Y. D. Wang has a total of 3 co-authors. Here are the top co-authors by number of shared publications:
- Guogui Sun
Department of Oncology Radiation Physics Technology Section, North China University of Science and Technology Affiliated Hospital, Tangshan, Hebei, 063000, China; Hebei Key Laboratory of Medical-Industrial Integration Precision Medicine, Tangshan, Hebei, 063000, China
1 shared publication - W. N. Hu
Tangshan People’s Hospital
1 shared publication - Y. J. Cheng
The Fourth Hospital of Hebei Medical University
1 shared publication
Latest Publications
- 27 June 2014
- Published by Springer Nature in Tumor Biology
- Vol. 35 (10) , 9707-9716
BTG1 underexpression is an independent prognostic marker in esophageal squamous cell carcinoma
To determine the expression and function of B cell translocation gene 1 (BTG1) in esophageal carcinoma, esophageal samples were taken from cancer lesions (n = 74) and adjacent normal tissue (n = 34) in esophageal cancer patients immediately after endoscopic biopsy. BTG1 expression was determined by immunohistochemistry and Western blotting. The effect of BTG1 overexpression was examined in vitro utilizing a human esophageal cancer cell line ECA-109 stably transfected with a recombinant lentivirus (LeBTG1 cells) and compared to empty vector-transfected controls (LeEmpty). BTG1 overexpression was verified by real-time reverse transcriptase polymerase chain reaction (RT-PCR) and Western blot. The expression of proteins involved in cell cycle regulation (cyclin D1) and apoptosis (Bcl-2) and cell migration (MMP-9) in LeBTG1 cells was analyzed by Western blot. The effect of BTG1 overexpression on cell viability and proliferation was assessed by an MTT assay in LeBTG1 and LeEmpty cells. Flow cytometric analyses were used to evaluate the effect of BTG1 expression on cell cycle distribution and apoptosis. The migration and invasion potential of LeBTG1 cells was examined by plating cells in Matrigel-coated chambers. The level of BTG1 protein expression was found to be significantly lower in esophageal cancer tissue than normal tissues (P P P MMP-9 protein expression compared with Eca-109 cell-untransfected BTG1 (P
- 27 June 2014
- Published by Springer Nature in Tumor Biology
- Vol. 35 (10) , 9707-9716
BTG1 underexpression is an independent prognostic marker in esophageal squamous cell carcinoma
To determine the expression and function of B cell translocation gene 1 (BTG1) in esophageal carcinoma, esophageal samples were taken from cancer lesions (n = 74) and adjacent normal tissue (n = 34) in esophageal cancer patients immediately after endoscopic biopsy. BTG1 expression was determined by immunohistochemistry and Western blotting. The effect of BTG1 overexpression was examined in vitro utilizing a human esophageal cancer cell line ECA-109 stably transfected with a recombinant lentivirus (LeBTG1 cells) and compared to empty vector-transfected controls (LeEmpty). BTG1 overexpression was verified by real-time reverse transcriptase polymerase chain reaction (RT-PCR) and Western blot. The expression of proteins involved in cell cycle regulation (cyclin D1) and apoptosis (Bcl-2) and cell migration (MMP-9) in LeBTG1 cells was analyzed by Western blot. The effect of BTG1 overexpression on cell viability and proliferation was assessed by an MTT assay in LeBTG1 and LeEmpty cells. Flow cytometric analyses were used to evaluate the effect of BTG1 expression on cell cycle distribution and apoptosis. The migration and invasion potential of LeBTG1 cells was examined by plating cells in Matrigel-coated chambers. The level of BTG1 protein expression was found to be significantly lower in esophageal cancer tissue than normal tissues (P P P MMP-9 protein expression compared with Eca-109 cell-untransfected BTG1 (P